Viewing Study NCT03172494


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-04-14 @ 10:01 PM
Study NCT ID: NCT03172494
Status: COMPLETED
Last Update Posted: 2022-12-14
First Post: 2017-05-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Sponsor: Novo Nordisk A/S
Organization: